1-4 of 4
Caroline A. Heckman
Close
Sort by
Journal Articles

Monosomy 7/del(7q) cause sensitivity to inhibitors of nicotinamide phosphoribosyltransferase in acute myeloid leukemia

Samuli Eldfors, Joseph Saad, Nemo Ikonen, Disha Malani, Markus Vähä-Koskela, Bjørn T. Gjertsen, Mika Kontro, Kimmo Porkka, Caroline A. Heckman
Journal: Blood Advances
Blood Adv (2024) 8 (7): 1621–1633.
https://doi.org/10.1182/bloodadvances.2023010435
Published: 2024
Includes: Supplemental data
Journal Articles

Heterogeneous modulation of Bcl-2 family members and drug efflux mediate MCL-1 inhibitor resistance in multiple myeloma

Arnold Bolomsky, Juho J. Miettinen, Alina Malyutina, Andrej Besse, Julia Huber, Stefanie Fellinger, Helene Breid, Alun Parsons, Kristaps Klavins, J. Thomas Hannich, Stefan Kubicek, Jo Caers, Wolfgang Hübl, Martin Schreder, Niklas Zojer, Christoph Driessen, Jing Tang, Lenka Besse, Caroline A. Heckman, Heinz Ludwig
Journal: Blood Advances
Blood Adv (2021) 5 (20): 4125–4139.
https://doi.org/10.1182/bloodadvances.2020003826
Published: 2021
Includes: Supplemental data
Journal Articles

Mutation accumulation in cancer genes relates to nonoptimal outcome in chronic myeloid leukemia

Clinical Trials & Observations
Shady Adnan Awad, Matti Kankainen, Teija Ojala, Perttu Koskenvesa, Samuli Eldfors, Bishwa Ghimire, Ashwini Kumar, Soili Kytölä, Mahmoud M. Kamel, Caroline A. Heckman, Kimmo Porkka, Satu Mustjoki
Journal: Blood Advances
Blood Adv (2020) 4 (3): 546–559.
https://doi.org/10.1182/bloodadvances.2019000943
Published: 2020
Includes: Supplemental data
Journal Articles

Crosstalk between ROR1 and BCR pathways defines novel treatment strategies in mantle cell lymphoma

Hanna Karvonen, David Chiron, Wilhelmiina Niininen, Sara Ek, Mats Jerkeman, Elaheh Moradi, Matti Nykter, Caroline A. Heckman, Olli Kallioniemi, Astrid Murumägi, Daniela Ungureanu
Journal: Blood Advances
Blood Adv (2017) 1 (24): 2257–2268.
https://doi.org/10.1182/bloodadvances.2017010215
Published: 2017
Includes: Supplemental data